formoterol

(redirected from Perforomist)
Also found in: Medical.
Related to Perforomist: Symbicort
Translations

formoterol

n formoterol m
References in periodicals archive ?
The asthma drugs are formoterol (Foradil, Perforomist, Symbicort, Dulera), albuterol, levalbuterol, metaproterenol, pirbuterol (Maxair), and terbutaline.
This is a lower dose than Foradil (12 meg/inhalation) or Perforomist administered in a liquid nebulizer (20 mcg/2 ml).
has been issued several additional United States patents protecting the company's Perforomist Inhalation Solution, a chronic obstructive pulmonary disease (COPD) treatment.
Lower-than-expected sales of Dey's Perforomist, an inhaler for chronic obstructive lung disease, prompted Mylan to begin looking for a buyer in February.
The newest formulation of formoterol is known as Perforomist, a wet nebulization ampoule containing 0.
Lexington MA) won approval for its Perforomist inhalable twice-a-day treatment for the respiratory ailments emphysema and chronic bronchitis.
The addition of TD-4208 to our pipeline is highly complementary with our existing respiratory portfolio, including our marketed nebulized COPD product, Perforomist Inhalation Solution, and reinforces Mylan's leadership in nebulized respiratory therapy," said Mylan CEO Heather Bresch.
Offsetting these declines, sales of the Perforomist Inhalation Solution increased from the comparable prior year period as a result of favorable pricing and volume.
Respiratory Market Presence 86 Perforomist (formoterol fumarate) 86 Levalbuterol 86 Acquisition of Respiratory Delivery Platform 87 Nephron Pharmaceuticals 88 Respiratory Market Presence 88 Sandoz 89 Respiratory Market Presence 89 In Development 89 Veramyst (fluticasone furoate) Litigation 89 Pulmicort Respules (budesonide) Litigation 90 Teva Pharmaceutical Industries 91 Respiratory Market Presence 91 Proair (albutero]) 91 Qvar (beclomethasone dipropionate) 91 Neovent/Sereflo (salmeterol xinafoate) 92 Generics 92 Sources 94 Index 95
Nasdaq: MYL) today announced the United States District Court for the Northern District of West Virginia issued a decision upholding the validity of all patents asserted by Mylan, protecting Perforomist (formoterol fumarate) Inhalation Solution.
In addition, Perforomist Inhalation Solution sales increased by double digits from the comparable prior year period as a result of favorable pricing.